2.95 USD
▼-0.10-3.28%
盘后 3.56 0.00%
2026-11-20
市值
$203.27M
市盈率
—
EPS
-2.03
股息率
—
52 周区间
2.88 – 7.83
成交量
89.08K
Beta
1.61
目标价
9.17
52W 低 2.8852W 高 7.83
价格走势
公司简介
Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company’s products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase II clinical trials for the treatment of high nectin-4 expressing tumors; nuzefatide pevedotin (EphA2), a BTC that is in phase I/II clinical trials to treat Ephrin type A receptor 2 expressing tumor; BT7480, a Bicycle tumor-targeted imm...